- Report
- March 2025
- 150 Pages
Global
From €5211EUR$5,950USD£4,523GBP
- Report
- August 2025
- 184 Pages
Global
From €3450EUR$3,939USD£2,994GBP
- Report
- January 2026
- 185 Pages
Global
From €3941EUR$4,500USD£3,421GBP
- Report
- March 2025
- 95 Pages
Global
From €3500EUR$4,281USD£3,144GBP
- Report
- April 2025
- 150 Pages
Brazil
From €5211EUR$5,950USD£4,523GBP
- Report
- November 2024
- 100 Pages
Brazil
From €5211EUR$5,950USD£4,523GBP
- Report
- November 2024
- 150 Pages
United States
From €5211EUR$5,950USD£4,523GBP
The Cattle Vaccine market is a segment of the Animal Healthcare/Veterinary industry that focuses on the development and distribution of vaccines for cattle. Vaccines are used to protect cattle from a variety of diseases, including bovine respiratory disease, bovine viral diarrhea, and foot-and-mouth disease. Vaccines are typically administered through injection or intranasal spray, and can be used to prevent or reduce the severity of disease. Vaccines are also used to improve the overall health of cattle, as well as to increase milk production and reduce the risk of disease transmission.
The Cattle Vaccine market is highly competitive, with a number of companies offering a variety of products. Major players in the market include Merck Animal Health, Boehringer Ingelheim, Zoetis, Elanco, and Ceva Animal Health. Other companies in the market include Virbac, Bayer Animal Health, and Phibro Animal Health. Show Less Read more